Effect of thioridazine on antioxidant status of HEMn-DP melanocytes
Thioridazine as an antipsychotic agent was extensively used to treat various psychotic disorders, e.g. schizophrenia. However, the therapy with this drug can induce serious side effects such as extrapyramidal symptoms or ocular and skin disorders, which mechanisms are still not fully established. To gain inside the molecular mechanisms underlying thioridazine toxicity, we examined the effect of this drug on cell viability, antioxidant defence system as well as melanogenesis in normal human melanocytes. It was demonstrated that thioridazine induces concentration-dependent loss in cell viability. The value of EC50 was calculated to be 2.24 μM. To study the effect of thioridazine on antioxidant defence system in melanocytes, the level of hydrogen peroxide and the activities of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase were determined. The drug in concentrations of 0.1, 0.25, 1.0 and 2.5 μM caused changes in cellular antioxidant defence system indicating the induction of oxidative stress. It was also shown that the analysed neuroleptic in concentrations of 1.0 and 2.5 μM significantly inhibited melanogenesis. The observed changes in cell viability, antioxidant defence system and melanization in normal human melanocytes after thioridazine treatment may explain an important role of reactive oxygen species as well as melanin in mechanisms involved in this drug side effects directed on pigmented tissues..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:388 |
|---|---|
| Enthalten in: |
Naunyn-Schmiedeberg's archives of pharmacology - 388(2015), 10, Seite 1097-1104 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Otręba, Michał [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antioxidant enzymes |
|---|
| doi: |
10.1007/s00210-015-1144-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1963412028 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1963412028 | ||
| 003 | DE-627 | ||
| 005 | 20230714161004.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00210-015-1144-z |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1963412028 | ||
| 035 | |a (DE-599)GBVOLC1963412028 | ||
| 035 | |a (PRQ)c2420-c5039bc9cd6fe791d3fff96983c9c7aea8704d986b7124447953cf7c8be801c10 | ||
| 035 | |a (KEY)0016515820150000388001001097effectofthioridazineonantioxidantstatusofhemndpmel | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Otręba, Michał |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of thioridazine on antioxidant status of HEMn-DP melanocytes |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Thioridazine as an antipsychotic agent was extensively used to treat various psychotic disorders, e.g. schizophrenia. However, the therapy with this drug can induce serious side effects such as extrapyramidal symptoms or ocular and skin disorders, which mechanisms are still not fully established. To gain inside the molecular mechanisms underlying thioridazine toxicity, we examined the effect of this drug on cell viability, antioxidant defence system as well as melanogenesis in normal human melanocytes. It was demonstrated that thioridazine induces concentration-dependent loss in cell viability. The value of EC50 was calculated to be 2.24 μM. To study the effect of thioridazine on antioxidant defence system in melanocytes, the level of hydrogen peroxide and the activities of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase were determined. The drug in concentrations of 0.1, 0.25, 1.0 and 2.5 μM caused changes in cellular antioxidant defence system indicating the induction of oxidative stress. It was also shown that the analysed neuroleptic in concentrations of 1.0 and 2.5 μM significantly inhibited melanogenesis. The observed changes in cell viability, antioxidant defence system and melanization in normal human melanocytes after thioridazine treatment may explain an important role of reactive oxygen species as well as melanin in mechanisms involved in this drug side effects directed on pigmented tissues. | ||
| 540 | |a Nutzungsrecht: © Springer-Verlag Berlin Heidelberg 2015 | ||
| 650 | 4 | |a Hydrogen peroxide | |
| 650 | 4 | |a Thioridazine | |
| 650 | 4 | |a Biomedicine | |
| 650 | 4 | |a Neurosciences | |
| 650 | 4 | |a Melanocytes | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Antioxidant enzymes | |
| 700 | 1 | |a Beberok, Artur |4 oth | |
| 700 | 1 | |a Wrześniok, Dorota |4 oth | |
| 700 | 1 | |a Rok, Jakub |4 oth | |
| 700 | 1 | |a Buszman, Ewa |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Naunyn-Schmiedeberg's archives of pharmacology |d Berlin : Springer, 1972 |g 388(2015), 10, Seite 1097-1104 |w (DE-627)129297666 |w (DE-600)121471-8 |w (DE-576)014490692 |x 0028-1298 |7 nnns |
| 773 | 1 | 8 | |g volume:388 |g year:2015 |g number:10 |g pages:1097-1104 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1007/s00210-015-1144-z |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26105001 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1709594913 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_287 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4277 | ||
| 912 | |a GBV_ILN_4306 | ||
| 951 | |a AR | ||
| 952 | |d 388 |j 2015 |e 10 |h 1097-1104 | ||